Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales.
Ferrera G, Mortellaro G, Mannino M, Caminiti G, Spera A, Figlia V, Iacoviello G, Di Paola G, Mazzola R, Lo Casto A, Alongi F, Pappalardo MP, Lagalla R. Ferrera G, et al. Among authors: di paola g. Radiol Med. 2015 Dec;120(12):1170-6. doi: 10.1007/s11547-015-0555-8. Epub 2015 May 24. Radiol Med. 2015. PMID: 26002724
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.
Mazzola R, Ricchetti F, Fiorentino A, Levra NG, Fersino S, Di Paola G, Ruggieri R, Alongi F. Mazzola R, et al. Among authors: di paola g. Technol Cancer Res Treat. 2017 Jun;16(3):310-315. doi: 10.1177/1533034616655055. Epub 2016 Jul 8. Technol Cancer Res Treat. 2017. PMID: 27402633 Free PMC article.
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.
Fersino S, Tebano U, Mazzola R, Giaj-Levra N, Ricchetti F, Di Paola G, Fiorentino A, Sicignano G, Naccarato S, Ruggieri R, Cavalleri S, Alongi F. Fersino S, et al. Among authors: di paola g. Clin Genitourin Cancer. 2017 Aug;15(4):e667-e673. doi: 10.1016/j.clgc.2017.01.025. Epub 2017 Feb 6. Clin Genitourin Cancer. 2017. PMID: 28237181
Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A, Giaj-Levra N, Tebano U, Mazzola R, Ricchetti F, Fersino S, Di Paola G, Aiello D, Ruggieri R, Alongi F. Fiorentino A, et al. Among authors: di paola g. Radiol Med. 2017 Sep;122(9):676-682. doi: 10.1007/s11547-017-0768-0. Epub 2017 Apr 26. Radiol Med. 2017. PMID: 28447313
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
Mazzola R, Cuccia F, Figlia V, Rigo M, Nicosia L, Giaj-Levra N, Ricchetti F, Vitale C, Mantoan B, Di Paola G, De Simone A, Gurrera D, Sicignano G, Naccarato S, Ruggieri R, Alongi F. Mazzola R, et al. Among authors: di paola g. Radiol Med. 2021 Jul;126(7):989-997. doi: 10.1007/s11547-021-01352-w. Epub 2021 Apr 9. Radiol Med. 2021. PMID: 33835309
201 results